Big Move For ERYTECH Pharma S.A.
Mon, Dec 30, 2019 at 05:30 PM
ERYTECH Pharma S.A. (ERYP:NASDAQ) shot up at $6.98, representing a gain of 37.9%. On Fri 27 Dec 19, ERYP:NASDAQ hit a New 2-Week High of $5.06. From Mon 25 Nov 19, the stock recorded 21.43% Up Days and 13.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About ERYTECH Pharma S.A. (ERYP:NASDAQ)
Erytech Pharma is a biopharmaceutical company. The Company's product ERY-ASP, named GRASPA 2 in Europe and Israel, is positioned in the treatment of acute leukemia, a cancer of the blood and bone marrow.
Top 10 Gainers:
- Savara Inc. (SVRA:NASDAQ), 183.82%
- InVivo Therapeutics Holdings Corp. (NVIV:NASDAQ), 61.28%
- Sol-Gel Technologies Ltd. (SLGL:NASDAQ), 58.18%
- NIO Inc. (NIO:NYSE), 53.72%
- Ocugen, Inc. (OCGN:NASDAQ), 44.75%
- Ra Medical Systems, Inc. (RMED:NYSE), 38.52%
- ERYTECH Pharma S.A. (ERYP:NASDAQ), 37.94%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 36.27%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 32.28%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 31.04%